FILE - In this Monday, Sept. 24, 2018 file photo, a patient undergoes dialysis at a clinic in Sacramento, Calif. Results of a study released on Sunday, April 14, 2019 show that the diabetes drug Invokana has been shown to help prevent or delay worsening of kidney disease, which causes millions of deaths each year and requires hundreds of thousands of people to use dialysis to stay alive. (AP Photo/Rich Pedroncelli)

Study finds diabetes drug may prevent, slow kidney disease

April 14, 2019 - 7:08 pm

A new study shows that a drug used to help control blood sugar in people with diabetes also can prevent or slow kidney disease, which causes millions of deaths each year and requires hundreds of thousands of people to use dialysis to stay alive.

Doctors say it's hard to overstate the importance of this study, and what it means for curbing this problem, which is growing because of the obesity epidemic.

The study tested the drug Invokana (in-vo-KAHN-ah) in people with Type 2 diabetes who were already getting standard treatments. Invokana lowered by 30% the risk of kidney failure, the need for dialysis or a kidney transplant or some other problems.

Results were discussed Sunday at a medical meeting in Australia and published by the New England Journal of Medicine.

___

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Department of Science Education. The AP is solely responsible for all content.

AP Editorial Categories: 
Comments ()